Faster access than browser!Similarities between NMDA receptor and Rislenemdaz
NMDA receptor and Rislenemdaz have 13 things in common (in Unionpedia): Apimostinel, Clinical trial, Efficacy, Glutamic acid, GRIN2B, Ketamine, Major depressive disorder, NMDA receptor, Receptor antagonist, Traxoprodil, Treatment-resistant depression, United States, 4-Chlorokynurenine.
Apimostinel
Apimostinel (former developmental code name NRX-1074) is an antidepressant, acting as a selective partial agonist of an allosteric site of the glycine site of the NMDA receptor complex, which is under investigation by Naurex and Allergan for the treatment of major depressive disorder (MDD).
Apimostinel and NMDA receptor · Apimostinel and Rislenemdaz ·
Clinical trial
Clinical trials are experiments or observations done in clinical research.
Clinical trial and NMDA receptor · Clinical trial and Rislenemdaz ·
Efficacy
Efficacy is the ability to get a job done satisfactorily.
Efficacy and NMDA receptor · Efficacy and Rislenemdaz ·
Glutamic acid
Glutamic acid (symbol Glu or E) is an α-amino acid with formula.
Glutamic acid and NMDA receptor · Glutamic acid and Rislenemdaz ·
GRIN2B
Glutamate receptor subunit epsilon-2, also known as N-methyl D-aspartate receptor subtype 2B (NMDAR2B or NR2B), is a protein that in humans is encoded by the GRIN2B gene.
GRIN2B and NMDA receptor · GRIN2B and Rislenemdaz ·
Ketamine
Ketamine, sold under the brand name Ketalar among others, is a medication mainly used for starting and maintaining anesthesia.
Ketamine and NMDA receptor · Ketamine and Rislenemdaz ·
Major depressive disorder
Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations.
Major depressive disorder and NMDA receptor · Major depressive disorder and Rislenemdaz ·
NMDA receptor
The N-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and ion channel protein found in nerve cells.
NMDA receptor and NMDA receptor · NMDA receptor and Rislenemdaz ·
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
NMDA receptor and Receptor antagonist · Receptor antagonist and Rislenemdaz ·
Traxoprodil
Traxoprodil (developmental code name CP-101606) is a drug developed by Pfizer which acts as an NMDA antagonist, selective for the NR2B subunit.
NMDA receptor and Traxoprodil · Rislenemdaz and Traxoprodil ·
Treatment-resistant depression
Treatment-resistant depression (TRD) or treatment-refractory depression is a term used in clinical psychiatry to describe cases of major depressive disorder (MDD) that do not respond adequately to appropriate courses of at least two antidepressants.
NMDA receptor and Treatment-resistant depression · Rislenemdaz and Treatment-resistant depression ·
United States
The United States of America (USA), commonly known as the United States (U.S.) or America, is a federal republic composed of 50 states, a federal district, five major self-governing territories, and various possessions.
NMDA receptor and United States · Rislenemdaz and United States ·
4-Chlorokynurenine
L-4-Chlorokynurenine (4-Cl-KYN; developmental code name AV-101) is an orally active small molecule prodrug of 7-chlorokynurenic acid, a NMDA receptor antagonist.
4-Chlorokynurenine and NMDA receptor · 4-Chlorokynurenine and Rislenemdaz ·
The list above answers the following questions
- What NMDA receptor and Rislenemdaz have in common
- What are the similarities between NMDA receptor and Rislenemdaz
NMDA receptor and Rislenemdaz Comparison
NMDA receptor has 238 relations, while Rislenemdaz has 24. As they have in common 13, the Jaccard index is 4.96% = 13 / (238 + 24).
References
This article shows the relationship between NMDA receptor and Rislenemdaz. To access each article from which the information was extracted, please visit:
